Join
Live feed
·
PRReleasevia Quantisnow
N2OFF Inc. logo

N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination

ByQuantisnow·Wall Street's wire, on your screen.
NITO· N2OFF Inc.
Industrials

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NITO (N2OFF Inc.) and more on Quantisnow.